Founded/Established in and Short synopsis of aims and objectives The European ME Alliance (EMEA) was founded in 2008 and is committed to increase understanding of Myalgic
Encephalomyelitis (ME or ME/CFS) and improve quality of life experienced by people with… Continue Reading

Become a member of the Resident and Research Fellow Section of the European Academy of Neurology (EAN-RRFS) and gain access to exclusive member benefits.

Two years ago, the European Academy of Neurology – Residents and Research Fellows Section (EAN-RRFS) started a new initiative called “junior national representatives network” to establish a team of junior national representatives within the EAN-RRFS. The main aim is to enable closer links between the European countries in order to facilitate the speed of information flow, exchange experiences, and learn from each other.

          by Anna Sauerbier       1) EFNA launch ‘Survey of Young Europeans with Neurological Conditions’ http://www.braincouncil.eu/activities/news/efna-launch-survey-of-young-europeans-with-neurological-conditions/   2) Europe’s pharma companies join with non-profit group in push to measure outcomes of medical treatments https://sciencebusiness.net/healthy-measures/news/europes-pharma-companies-join-non-profit-group-push-measure-outcomes-medical… Continue Reading

History Machado-Joseph disease (MJD) is an autosomal dominant (AD) spinocerebellar ataxia (SCA) initially described in descendants of immigrants from the Portuguese islands of the Azores. It was in 1972 that Kenneth K. Nakano and colleagues described the Machado family, with an AD, late onset, cerebellar ataxia with peripheral neuropathy. All family members were descendants from Guilherme Machado, who had migrated from São Miguel (Azores) to Massachusetts in the late nineteenth or early twentieth centuries.

For April 2018, we have selected: Whelan CD, Altmann A, Botia JA, et al., for the ENIGMA-Epilepsy Working Group. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain 2018;141:391-408. Epilepsy affects 0.6-1.5% of the population worldwide with one-third of patients being resistant to antiepileptic treatment. Nowadays epilepsy is considered a network disorder in which several structural changes are involved.

Slovakia, officially the Slovak Republic, is a country in Central Europe. The total area of the Slovak territory is 49 036 km2 and is mostly mountainous. The population is over 5 million. The capital and largest city is Bratislava. However, the Slovak Republic is a young state (established on January 1st, 1993, by the split of Czechoslovakia), indeed it is an old country with rich historical heritage.

by Prof. Radu Tanasescu   Paper: Maggi et al. ‘Central Vein Sign Differentiates Multiple Sclerosis from Central Nervous System Inflammatory Vasculopathies’. Annals of Neurology. 2018;83:283–294. Outline: This paper shows for the first time that central vein assessment in white matter… Continue Reading

THE EUROPEAN ACADEMY OF NEUROLOGY PRESENTS ‘CHALLENGING THE GLOBAL BURDEN OF BRAIN DISEASE’, A COLLABORATION WITH ITN PRODUCTIONS In a unique communications partnership, European Academy of Neurology (EAN) and ITN Productions are producing a news and current affairs-style programme highlighting… Continue Reading

Epilepsy Center, Neurocenter, Kuopio University Hospital and Faculty of Health Sciences, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

This Brain Awareness Week EFNA are launching a Survey of Young Europeans with Neurological Conditions.

On 12-14 April the Dystonia Europe 25th Anniversary Conference and D-DAYs 2018 will take place in Brussels, Belgium. The 3-day event will include a special lunch in the EU Parliament.